0001493152-21-005913.txt : 20210312 0001493152-21-005913.hdr.sgml : 20210312 20210312165758 ACCESSION NUMBER: 0001493152-21-005913 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210310 FILED AS OF DATE: 20210312 DATE AS OF CHANGE: 20210312 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Freeburg Thomas John CENTRAL INDEX KEY: 0001736975 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-24249 FILM NUMBER: 21738281 MAIL ADDRESS: STREET 1: INTERPACE DIAGNOSTICS GROUP, INC. STREET 2: 300 INTERPACE PKWY, BLDG. C CITY: PARSIPPANY STATE: NJ ZIP: 07054 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INTERPACE BIOSCIENCES, INC. CENTRAL INDEX KEY: 0001054102 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 222919486 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: MORRIS CORPORATE CENTER 1, STREET 2: BUILDING C, 300 INTERPACE PARKWAY CITY: PARSIPPANY STATE: NJ ZIP: 07054 BUSINESS PHONE: 412-224-6100 MAIL ADDRESS: STREET 1: MORRIS CORPORATE CENTER 1, STREET 2: BUILDING C, 300 INTERPACE PARKWAY CITY: PARSIPPANY STATE: NJ ZIP: 07054 FORMER COMPANY: FORMER CONFORMED NAME: Interpace Diagnostics Group, Inc. DATE OF NAME CHANGE: 20151223 FORMER COMPANY: FORMER CONFORMED NAME: PDI INC DATE OF NAME CHANGE: 20021113 FORMER COMPANY: FORMER CONFORMED NAME: PROFESSIONAL DETAILING INC DATE OF NAME CHANGE: 19980129 4 1 ownership.xml X0306 4 2021-03-10 0 0001054102 INTERPACE BIOSCIENCES, INC. IDGX 0001736975 Freeburg Thomas John INTERPACE BIOSCIENCES, INC 300 INTERPACE PARKWAY PARSIPPANY NJ 07054 0 1 0 0 Chief Financial Officer Common Stock 2021-03-10 4 A 0 50000 A 52000 D Stock Option (right to buy) 6.00 2021-03-10 4 A 0 50000 0 A 2031-03-10 Common Stock 50000 50000 D The restricted stock units vest annually, in equal installments, over a three-year period, commencing on March 10, 2021. Each restricted stock unit represents the contingent right to receive one share of common stock of the Issuer. The stock options vest and become exercisable over a three-year period, in equal installments, commencing on March 10, 2021, subject to the reporting person's continued service with the Issuer. /s/ Thomas John Freeburg 2021-03-12